Epigenetics alternation in lung fibrosis and lung cancer
Respiratory disease including interstitial lung diseases (ILDs) and lung cancer is a group of devastating diseases that linked with increased morbidity and healthcare burden. However, respiratory diseases cannot be fully explained by the alternation of genetic information. Genetic studies described...
Main Authors: | Xueren Li, Chunjing Feng, Shouchun Peng |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1060201/full |
Títulos similares
-
Epigenetic Therapy in Lung Cancer
por: Stephen V Liu, et al.
Publicado: (2013-05-01) -
Epigenetics as a versatile regulator of fibrosis
por: Yangdan Liu, et al.
Publicado: (2023-03-01) -
Progress of Epigenetic Methylation in Lung Cancer Research
por: Shaowei ZHANG, et al.
Publicado: (2017-09-01) -
Epigenetic mechanisms and their effects on cancer incidence and treatment: a review study
por: Reyhane Hoshyar, et al.
Publicado: (2015-07-01) -
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
por: Runping Liu, et al.
Publicado: (2024-03-01)